X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (517) 517
oncology (360) 360
index medicus (320) 320
clinical neurology (241) 241
adult (233) 233
chemotherapy (229) 229
female (229) 229
male (224) 224
gliomas (203) 203
brain neoplasms - drug therapy (201) 201
middle aged (199) 199
brain neoplasms - pathology (160) 160
medicine & public health (157) 157
glioblastoma (154) 154
radiation-therapy (144) 144
aged (143) 143
glioma - drug therapy (143) 143
radiotherapy (143) 143
temozolomide (142) 142
phase-ii trial (140) 140
cancer (134) 134
glioma (129) 129
brain neoplasms - therapy (117) 117
recurrent glioblastoma (117) 117
glioma - pathology (116) 116
malignant glioma (113) 113
recurrent (113) 113
brain tumors (112) 112
surgery (112) 112
prognosis (110) 110
glioblastoma-multiforme (109) 109
treatment outcome (107) 107
tumors (100) 100
care and treatment (96) 96
neurology (84) 84
combined modality therapy (83) 83
antineoplastic combined chemotherapy protocols - therapeutic use (81) 81
glioma - therapy (80) 80
phase-ii (80) 80
adolescent (79) 79
antineoplastic agents - therapeutic use (79) 79
survival (79) 79
dacarbazine - analogs & derivatives (78) 78
high-grade gliomas (78) 78
brain-tumors (77) 77
brain neoplasms - mortality (76) 76
brain neoplasms - surgery (76) 76
retrospective studies (75) 75
bevacizumab (72) 72
brain neoplasms - genetics (72) 72
brain neoplasms - radiotherapy (71) 71
glioblastoma multiforme (71) 71
recurrent malignant glioma (70) 70
brain cancer (68) 68
neurosciences (68) 68
newly-diagnosed glioblastoma (66) 66
oligodendroglioma (65) 65
high-grade glioma (61) 61
magnetic resonance imaging (61) 61
malignant gliomas (61) 61
recurrent malignant gliomas (61) 61
brain neoplasms - diagnosis (60) 60
animals (59) 59
child (59) 59
research (58) 58
neoplasm recurrence, local - drug therapy (55) 55
radiology, nuclear medicine & medical imaging (55) 55
recurrent glioma (55) 55
survival analysis (55) 55
brain (53) 53
central-nervous-system (53) 53
glioblastoma - drug therapy (53) 53
oligodendroglioma - drug therapy (52) 52
survival rate (52) 52
prognostic-factors (51) 51
recurrent glioblastoma-multiforme (51) 51
health aspects (50) 50
antineoplastic agents, alkylating - therapeutic use (49) 49
dacarbazine - therapeutic use (49) 49
disease-free survival (48) 48
disease progression (47) 47
glioma - mortality (47) 47
diagnosis (46) 46
adjuvant temozolomide (45) 45
pharmacology & pharmacy (45) 45
therapy (45) 45
analysis (44) 44
clinical trials as topic (43) 43
young adult (43) 43
immunotherapy (42) 42
neurosurgery (42) 42
glioma - radiotherapy (41) 41
radiation (41) 41
anaplastic oligodendroglioma (40) 40
article (40) 40
brain tumor (40) 40
child, preschool (40) 40
clinical trials (40) 40
development and progression (40) 40
glioma - genetics (40) 40
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of Clinical Oncology, ISSN 0732-183X, 01/2013, Volume 31, Issue 3, pp. 344 - 350
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 04/2016, Volume 374, Issue 14, pp. 1344 - 1355
Journal Article
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 1994, Volume 12, Issue 10, pp. 2013 - 2021
Purpose: To examine the rate and duration of response of anaplastic oligodendrogliomas to a dose-escalated combination chemotherapy regimen consisting of... 
ADJUVANT CHEMOTHERAPY | RESPONSE CRITERIA | ONCOLOGY | RECURRENT MALIGNANT OLIGODENDROGLIOMA | GLIOMA | POSTOPERATIVE RADIOTHERAPY | CONTRAST ENHANCEMENT | CCNU-CHEMOTHERAPY | COOPERATIVE-ONCOLOGY-GROUP | RADIATION-THERAPY | BRAIN-TUMORS
Journal Article
Current Treatment Options in Oncology, ISSN 1527-2729, 12/2013, Volume 14, Issue 4, pp. 505 - 513
Anaplastic oligodendroglial tumors have gained increasing interest with the emerging role of molecular markers and systemic chemotherapy during the past years.... 
Chemotherapy | Medicine & Public Health | Irradiation | Oncology | Procarbazine, lomustine and vincristin | Temozolomide | Anaplastic oligodendroglioma | BEVACIZUMAB | GLIOMA | LOMUSTINE | VINCRISTINE CHEMOTHERAPY | PHASE-III TRIAL | BRAIN-TUMOR | ADJUVANT PROCARBAZINE | ONCOLOGY | RECURRENT | RADIOTHERAPY | Care and treatment | Usage | Reports | Forecasts and trends | Radiotherapy | Oligodendroglioma | Cancer | Index Medicus
Journal Article
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2017, Volume 18, Issue 6, pp. e315 - e329
Journal Article
Neurology, ISSN 0028-3878, 05/2004, Volume 62, Issue 10, pp. 1783 - 1787
Background: Favorable prognostic factors for oligodendroglial tumors include age younger than 40 years, low tumor grade, and extent of resection. Objective: To... 
TEMOZOLOMIDE CHEMOTHERAPY | PHASE-II TRIAL | RECURRENT OLIGODENDROGLIOMA | PROGNOSTIC-FACTORS | LOW-GRADE GLIOMA | ANAPLASTIC GLIOMAS | QUALITY-OF-LIFE | CLINICAL NEUROLOGY | RADIATION-THERAPY | RANDOMIZED TRIAL | BRAIN-TUMORS | Procarbazine - administration & dosage | Nitrosourea Compounds - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Prognosis | Follow-Up Studies | Brain Neoplasms - diagnostic imaging | Humans | Middle Aged | Brain Neoplasms - pathology | Male | Life Tables | Brain Neoplasms - complications | Epilepsies, Partial - etiology | Cisplatin - administration & dosage | Dacarbazine - analogs & derivatives | Vincristine - administration & dosage | Adult | Female | Neoadjuvant Therapy | Technetium Tc 99m Sestamibi | Brain Neoplasms - mortality | Radiopharmaceuticals | Oligodendroglioma - mortality | Dacarbazine - administration & dosage | Proportional Hazards Models | Etoposide - administration & dosage | Treatment Outcome | Combined Modality Therapy | Oligodendroglioma - complications | Cranial Irradiation | Magnetic Resonance Imaging | Oligodendroglioma - therapy | Oligodendroglioma - pathology | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Biopsy | Adolescent | Brain Neoplasms - therapy | Radionuclide Imaging | Survival Analysis | Craniotomy | Aged | Organophosphorus Compounds - administration & dosage | Temozolomide | Lomustine - administration & dosage | Oligodendroglioma - diagnostic imaging
Journal Article
by Kim, JN and Jang, WY and Jung, TY and Jung, S and Kim, KK and Kim, HS and Kim, EH and Lee, MC and Moon, KS and Lee, KH
FRONTIERS IN ONCOLOGY, ISSN 2234-943X, 08/2019, Volume 9, p. 828
Following the introduction of the molecular classification of gliomas by the WHO in 2016, molecularly-proven lineage conversion during glioma recurrence has... 
OLIGOASTROCYTOMA | mixed oligoastrocytoma | 1p/19q-codeletion | ATRX | GENOMIC ANALYSIS | CLASSIFICATION | recurrent glioma | genetic heterogeneity | HETEROGENEITY | GLIOBLASTOMA | EVOLUTION | clonal evolution | ONCOLOGY | cell lineage | MUTATIONS | REVEALS | Usage | Genetic aspects | Nucleotide sequencing | Research | Diagnosis | Gene expression | Astrocytoma | Risk factors | DNA sequencing
Journal Article